Global DNA sequencing market
Global DNA sequencing market was valued US$ 7.9 Bn in 2017 and is expected to reach US$ 29.6 Bn by 2026, at a CAGR of 17.95 % during a forecast period. The DNA sequencing market is segmented into a product, application, technology, end-user, and region. In terms of product, a DNA sequencing market is segmented into consumables, instruments, and services. Based on the application segment, a DNA sequencing market is classified into biomarkers & cancer, diagnostics, reproductive health, personalized medicine, and forensics. Further technology, a DNA sequencing market is divided into sequencing by synthesis, ion semiconductor sequencing, sequencing by ligation, pyrosequencing, single-molecule-real-time sequencing, chain termination sequencing, and nanopore sequencing. In terms of the end-user, the DNA sequencing market is classified into academic & government research institutes, pharmaceutical companies, biotechnology companies, and hospitals & clinics. Based on regions, the global DNA sequencing market is divided into five main regions are North America, Europe, Asia-pacific, Latin America and Middle East & Africa. In terms of product, the consumables product segment occupies the highest share in the DNA sequencing product market, owing to their sheer usage & need throughout the sample preparation, library construction, and other pre-requisite steps of DNA sequencing. Based on technology, the sequencing by synthesis technology segment is anticipated to dominate the global DNA sequencing market due to the widely-used DNA sequencing platforms as well as utilize sequencing by synthesis technology in sequencing protocols. Pyrosequencing technology is expected to witness the highest growth rate during the forecast period. The major driving factor of the global DNA sequencing market is growing breeder’s requirement for animals & plants reproduction, developing technology and applied markets, and increasing research and development in the DNA sequencing market. Additionally, the increasing prevalence of cancer cases and the entry of new market players is also boosting the market growth. Accuracy & standardization concerns in diagnostic testing, a high cost of development and maintenance, and lack of skilled professionals is limiting the growth of the global DNA sequencing market. Limitations in bioinformatics and social & ethical issues are some key challenges of the global DNA sequencing market. The major opportunity of the global DNA sequencing market is growing in developing countries and the influence of personalized medicine & biomarker discovery. Geographically, Asia-Pacific market is anticipated to the fastest-growing region for the global DNA Sequencing market due to the large patient population and growing healthcare infrastructure and expenditure. Europe is anticipated to drive the growth of the DNA sequencing market during the forecast period due to increasing incidences of an aging population suffering from cancer, sedentary lifestyle, and an efficient reimbursement scenario. Key player operating in the global DNA sequencing market are ZS Genetics, Siemens AG, Pacific Biosciences, Myriad Genetics, Microchip Biotechnologies, Johnson & Johnson, Integrated DNA Technologies, Hamilton Thorne Biosciences, Commonwealth Biotechnologies, Bayer Corporation, Agilent Technologies, Abbott Laboratories, Abbott Laboratories, LI-COR Biosciences, GE Healthcare Life Sciences and 454 Life Sciences.
The Scope of Global DNA Sequencing Market:Global DNA Sequencing Market, by Product:- Consumables • Instruments • Services
- Biomarkers & Cancer • Diagnostics • Reproductive Health • Personalized Medicine • Forensics
- Sequencing by synthesis • Ion semiconductor sequencing • Sequencing by ligation • Pyrosequencing • Single-molecule-real-time sequencing • Chain termination sequencing • Nanopore sequencing
- Academic & government research institutes • Pharmaceutical companies • Biotechnology companies • Hospitals & Clinics
- North America • Europe • Asia Pacific • Latin America • Middle East & Africa
- ZS Genetics • Siemens AG • Pacific Biosciences • Myriad Genetics • Microchip Biotechnologies • Johnson & Johnson • Integrated DNA Technologies • Hamilton Thorne Biosciences • Commonwealth Biotechnologies • Bayer Corporation • Agilent Technologies • Abbott Laboratories • Abbott Laboratories • LI-COR Biosciences • GE Healthcare Life Sciences • 454 Life Sciences
Customization of the report:
Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.
About Maximize Market Research:
Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.